157 related articles for article (PubMed ID: 22316593)
21. Role of diffusion weighted imaging in differentiation of intracranial tuberculoma and tuberculous abscess from cysticercus granulomas-a report of more than 100 lesions.
Gupta RK; Prakash M; Mishra AM; Husain M; Prasad KN; Husain N
Eur J Radiol; 2005 Sep; 55(3):384-92. PubMed ID: 16129246
[TBL] [Abstract][Full Text] [Related]
22. Apparent diffusion coefficient of diffusion weighted MRI in endometrial carcinoma-Relationship with local invasiveness.
Cao K; Gao M; Sun YS; Li YL; Sun Y; Gao YN; Zhang XP
Eur J Radiol; 2012 Aug; 81(8):1926-30. PubMed ID: 21592709
[TBL] [Abstract][Full Text] [Related]
23. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer.
Sumi M; Sakihama N; Sumi T; Morikawa M; Uetani M; Kabasawa H; Shigeno K; Hayashi K; Takahashi H; Nakamura T
AJNR Am J Neuroradiol; 2003 Sep; 24(8):1627-34. PubMed ID: 13679283
[TBL] [Abstract][Full Text] [Related]
24. Comparison between malignant and benign abdominal lymph nodes on diffusion-weighted imaging.
Akduman EI; Momtahen AJ; Balci NC; Mahajann N; Havlioglu N; Wolverson MK
Acad Radiol; 2008 May; 15(5):641-6. PubMed ID: 18423322
[TBL] [Abstract][Full Text] [Related]
25. Diffusion-Weighted Imaging (DWI) derived from PET/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC).
Freihat O; Pinter T; Kedves A; Sipos D; Cselik Z; Repa I; Kovács Á
Cancer Imaging; 2020 Aug; 20(1):56. PubMed ID: 32771060
[TBL] [Abstract][Full Text] [Related]
26. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient.
Nakayama J; Miyasaka K; Omatsu T; Onodera Y; Terae S; Matsuno Y; Cho Y; Hida Y; Kaga K; Shirato H
J Comput Assist Tomogr; 2010 Jan; 34(1):1-8. PubMed ID: 20118713
[TBL] [Abstract][Full Text] [Related]
27. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
28. Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging.
Eiber M; Beer AJ; Holzapfel K; Tauber R; Ganter C; Weirich G; Krause BJ; Rummeny EJ; Gaa J
Invest Radiol; 2010 Jan; 45(1):15-23. PubMed ID: 19996762
[TBL] [Abstract][Full Text] [Related]
29. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
30. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
[TBL] [Abstract][Full Text] [Related]
31. Role of diffusion-weighted MR imaging in cervical lymphadenopathy.
Abdel Razek AA; Soliman NY; Elkhamary S; Alsharaway MK; Tawfik A
Eur Radiol; 2006 Jul; 16(7):1468-77. PubMed ID: 16557366
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma.
de Bondt RB; Hoeberigs MC; Nelemans PJ; Deserno WM; Peutz-Kootstra C; Kremer B; Beets-Tan RG
Neuroradiology; 2009 Mar; 51(3):183-92. PubMed ID: 19137282
[TBL] [Abstract][Full Text] [Related]
33. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
[TBL] [Abstract][Full Text] [Related]
34. Mediastinal lymph nodes: assessment with diffusion-weighted MR imaging.
Koşucu P; Tekinbaş C; Erol M; Sari A; Kavgaci H; Oztuna F; Ersöz S
J Magn Reson Imaging; 2009 Aug; 30(2):292-7. PubMed ID: 19629990
[TBL] [Abstract][Full Text] [Related]
35. Diffusion-weighted magnetic resonance imaging in neck lymph adenopathy.
Vandecaveye V; De Keyzer F; Hermans R
Cancer Imaging; 2008 Sep; 8(1):173-80. PubMed ID: 18824423
[TBL] [Abstract][Full Text] [Related]
36. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.
Kim CK; Park BK; Han JJ; Kang TW; Lee HM
J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295
[TBL] [Abstract][Full Text] [Related]
37. Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses.
Lee SS; Byun JH; Park BJ; Park SH; Kim N; Park B; Kim JK; Lee MG
J Magn Reson Imaging; 2008 Oct; 28(4):928-36. PubMed ID: 18821618
[TBL] [Abstract][Full Text] [Related]
38. Clinical application of body diffusion weighted MR imaging in the diagnosis and preoperative N staging of cervical cancer.
Xue HD; Li S; Sun F; Sun HY; Jin ZY; Yang JX; Yu M
Chin Med Sci J; 2008 Sep; 23(3):133-7. PubMed ID: 18853846
[TBL] [Abstract][Full Text] [Related]
39. Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T.
Wang CL; Chea YW; Boll DT; Samei E; Neville AM; Dale BM; Merkle EM
Eur J Radiol; 2011 Nov; 80(2):e1-7. PubMed ID: 20646887
[TBL] [Abstract][Full Text] [Related]
40. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions.
Miller FH; Hammond N; Siddiqi AJ; Shroff S; Khatri G; Wang Y; Merrick LB; Nikolaidis P
J Magn Reson Imaging; 2010 Jul; 32(1):138-47. PubMed ID: 20578020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
